Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Depreciation & Amortization (CF) (2023 - 2025)

Camp4 Therapeutics' Depreciation & Amortization (CF) history spans 3 years, with the latest figure at $372000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 11.0% year-over-year to $372000.0; the TTM value through Dec 2025 reached $1.6 million, down 3.36%, while the annual FY2025 figure was $1.6 million, 3.36% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $372000.0 at Camp4 Therapeutics, down from $416000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $436000.0 in Q1 2024 and bottomed at $372000.0 in Q4 2025.
  • The 3-year median for Depreciation & Amortization (CF) is $421000.0 (2025), against an average of $418888.9.
  • The largest YoY upside for Depreciation & Amortization (CF) was 1.42% in 2025 against a maximum downside of 11.0% in 2025.
  • A 3-year view of Depreciation & Amortization (CF) shows it stood at $435000.0 in 2023, then decreased by 3.91% to $418000.0 in 2024, then fell by 11.0% to $372000.0 in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Depreciation & Amortization (CF) are $372000.0 (Q4 2025), $416000.0 (Q3 2025), and $430000.0 (Q2 2025).